|
"chiu c f"的相關文件
顯示項目 41-65 / 73 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-01-05T03:34:41Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Cheng A.-L.; Chen P.-J.; Liu T.-W.; Lin S.-J.; Wang M.-C.; MING YAO; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Hsu C.; Tsou H.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:37Z |
Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement
|
Chiou T.-J.; Chen T.Y.; Chang C.-S.; Chang M.-C.; Ko B.-S.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; Tang J.-L.; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020-12-28T08:14:14Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
Li H.-Y.; Fan S.-C.; Lin P.-H.; YEN-HSUAN NI; Chiu C.-F.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T. |
| 臺大學術典藏 |
2020-08-11T08:36:43Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.;Cheng A.-L.;Park J.-W.;Park J.H.;Po-Chin Liang;Hidaka H.;Izumi N.;Heo J.;Lee Y.J.;Sheen I.-S.;Chiu C.-F.;Arioka H.;Morita S.;Arai Y.; Kudo M.; Cheng A.-L.; Park J.-W.; Park J.H.; PO-CHIN LIANG; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
| 臺大學術典藏 |
2020-07-03T08:45:41Z |
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
|
Lai H.-H;Li C.-W;Hong C.-C;Sun H.-Y;Chiu C.-F;Da-Liang Ou;Chen P.-S.; Lai H.-H; Li C.-W; Hong C.-C; Sun H.-Y; Chiu C.-F; DA-LIANG OU; Chen P.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia
|
Lin P.-H;Chiu C.-F;Yen-Shen Lu; Lin P.-H; Chiu C.-F; YEN-SHEN LU |
| 臺大學術典藏 |
2020-05-25T06:51:44Z |
Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients
|
Dai M.-S;Chao T.-Y;Chao T.-C;Chiu C.-F;Yen-Shen Lu;Shiah H.-S;Wu Y.-Y;Gerald Fetterly G;Hung N;Cutler D.L;Kwan R;Douglas Kramer D;Chan W.-K;Hung T.; Dai M.-S; Chao T.-Y; Chao T.-C; Chiu C.-F; YEN-SHEN LU; Shiah H.-S; Wu Y.-Y; Gerald Fetterly G; Hung N; Cutler D.L; Kwan R; Douglas Kramer D; Chan W.-K; Hung T. |
| 臺大學術典藏 |
2020-04-28T07:12:44Z |
Blood flow driven by surface tension in a microchannel
|
Kung, C.F.; Chiu, C.F.; Chen, C.F.; Chang, C.C.; Chu, C.C.; CHIN-CHOU CHU |
| 臺大學術典藏 |
2020-04-28T07:11:38Z |
Blood flow driven by surface tension in a microchannel
|
Kung, C.F.; Chiu, C.F.; Chen, C.F.; Chang, C.C.; Chu, C.C.; CHIEN-CHENG CHANG |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Chiun Hsu; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-20T02:57:00Z |
MiR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression
|
Hong C.-C.; Chen P.-S.; Chiou J.; Chiu C.-F.; CHING-YAO YANG; Hsiao M.; Chang Y.-W.; Yu Y.-H.; Hung M.-C.; Hsu N.-W.; Shiah S.-G.; Hsu N.-Y.; Su J.-L. |
| 臺大學術典藏 |
2020-02-12T05:48:26Z |
Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-κB Signaling in Cervical Cancer
|
Su J.-L.;LING-HUNG WEI;Chen C.-A;Hsiao M;Cheng C.-C;Hong C.-C;Chiu C.-F;Chen M.-W;Chang Y.-W; Chang Y.-W; Chen M.-W; Chiu C.-F; Hong C.-C; Cheng C.-C; Hsiao M; Chen C.-A; LING-HUNG WEI; Su J.-L. |
| 臺大學術典藏 |
2020-01-22T07:50:32Z |
Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-�eB Signaling in Cervical Cancer
|
Chang Y.-W.; Chen M.-W.; Chiu C.-F.; Hong C.-C.; Cheng C.-C.; Hsiao M.; CHI-AN CHEN; Wei L.-H.; Su J.-L. |
| 臺大學術典藏 |
2020 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 國立交通大學 |
2019-04-03T06:47:40Z |
Optical Properties Study in Qusai Three Dimensional Aluminum Metallic Photonic Crystal
|
Wu, S-C; Lee, Y. -J.; Chang, K. -H.; Lin, S. -Y; Cho, A. -T.; Chiu, C. -F.; Huang, C. -D; Sha, J. -R. |
| 臺大學術典藏 |
2018-09-10T18:04:58Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, M.;Cheng, A.-L.;Park, J.-W.;Park, J.H.;Liang, P.-C.;Hidaka, H.;Izumi, N.;Heo, J.;Lee, Y.J.;Sheen, I.-S.;Chiu, C.-F.;Arioka, H.;Morita, S.;Arai, Y.; PO-CHIN LIANG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:48:02Z |
A 28.6μW mixed-signal processor for epileptic seizure detection
|
Chen, T.-J.;Lee, S.-C.;Yang, C.-H.;Chiu, C.-F.;Chiueh, H.; Chen, T.-J.; Lee, S.-C.; Yang, C.-H.; Chiu, C.-F.; Chiueh, H.; CHIA-HSIANG YANG |
| 臺大學術典藏 |
2018-09-10T08:49:58Z |
Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: A subanalysis of the EPIC study of deferasirox
|
Ibrahim, Hishamshah; Ha, Shau-Yin; Ho, Phoebe Joy; Li, Chi-Kong; Chan, Lee-Lee; Chiu, Chang-Fang; Sutcharitchan, Pranee; Habr, Dany; Domokos, Gabor; Roubert, Bernard; Xue, Hong-Ling; Bowden, Donald K.; Lin, Kai-Hsin; Viprakasit, Vip; KAI-HSIN LIN; Viprakasit, V.;Ibrahim, H.;Ha, S.-Y.;Ho, P.J.;Li, C.-K.;Chan, L.-L.;Chiu, C.-F.;Sutcharitchan, P.;Habr, D.;Domokos, G.;Roubert, B.;Xue, H.-L.;Bowden, D.K.;Lin, K.-H.邱昌芳;林凱信viprakasit, Vip; Ibrahim, Hishamshah; Ha, Shau-Yin; Ho, Phoebe Joy; Li, Chi-Kong; Chan, Lee-Lee; Chiu, Chang-Fang; Sutcharitchan, Pranee; Habr, Dany; Domokos, Gabor; Roubert, Bernard; Xue, Hong-Ling; Bowden, Donald K.; Lin, Kai-Hsin |
| 臺大學術典藏 |
2018-09-10T06:56:15Z |
A 43 GHz 0.13μm CMOS prescaler
|
Luo, T.-N.; Bai, S.-Y.; Chen, Y-J.E.; Ko, C.-L.; Chiu, C.-F.; Juang, Y.-Z.; YI-JAN EMERY CHEN |
| 臺大學術典藏 |
2018-09-10T06:30:11Z |
The unusual electrochemical and photophysical behavior of 2,2 '-bis(1,3,4-oxadiazol-2-yl)biphenyls, effective electron transport hosts for phosphorescent organic light emitting diodes
|
Leung, M. K.; Yang, C. C.; Lee, J. H.; Tsai, H. H.; Lin, C. F.; Huang, C. Y.; Su, Y. O.; Chiu, C. F.; JIUN-HAW LEE |
| 國立成功大學 |
2016 |
Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Siveke, Jens T.;Chen, Li-Tzong;Von Hoff, Daniel D;Li, Chung-Pin;Wang-Gillam, Andrew;Bodoky, Gyorgy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayel S;Macarulla, T.;Lee, K-H;Cunningham, D.;Blanc, J-F;Hubner, R. A.;Chiu, C-F;Schwartsmann, G.;Braiteh, F.;Moyo, V.;Belanger, B.;Bayever, E. |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 國立臺灣科技大學 |
2015 |
Improving performance and lifetime of small-molecule organic photovoltaic devices by using bathocuproine-fullerene cathodic layer
|
Liu, S.-W.;Lee, C.-C.;Su, W.-C.;Yuan, C.-H.;Shu, Y.-S.;Chang, W.-C.;Guo, J.-Y.;Chiu, C.-F.;Li, Y.-Z.;Su, T.-H.;Chen, K.-T.;Chang, P.-C.;Yeh, T.-H.;Liu, Y.-H. |
| 臺大學術典藏 |
2015 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
on behalf of the Taiwan Cooperative Oncology Group; Wei T.-C.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Chang J.Y.; Yu M.S.; Yang Y.; Hsieh R.K.; Chiu C.F.; Rau K.M.; Lee K.D.; Shiah H.S.; Chang I.C.; Bai L.Y.; Huang S.F.; Tsou H.H.; Tsai C.S.; Chiang N.J.; CHIH-HUNG HSU; Chen J.S.; Chen J.S.;Chih-Hung Hsu;Chiang N.J.;Tsai C.S.;Tsou H.H.;Huang S.F.;Bai L.Y.;Chang I.C.;Shiah H.S.;Ho C.L.;Yen C.J.;Lee K.D.;Chiu C.F.;Rau K.M.;Yu M.S.;Yang Y.;Hsieh R.K.;Chang J.Y.;Shan Y.S.;Chao Y.;Chen L.-T.;Chin Y.-H.;Chung T.-R.;Yu W.-L.;Lee M.-H.;Lin L.-F.;Lin P.-C.;Wu Y.-L.;Wang H.-L.;Lu L.-J.;Chen S.-Y.;Wu C.-C.;Wei T.-C.;On Behalf Of The Taiwan Cooperative Oncology Group; Yen C.J.; Ho C.L. |
| 臺大學術典藏 |
2014 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Wang M.-C.; Lin S.-J.; Tsou H.-H.; Hsu C.; Cheng A.-L.; Liu T.-W.; Chen P.-J.; HWEI-FANG TIEN; Chang C.-S.; Lin J.; Lin S.-F.; Chiu C.-F.; Kao W.-Y.; Yao M.; Hwang W.-L. |
顯示項目 41-65 / 73 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
